- Home
- LVO vs PDSB Comparison
LVO vs PDSB Comparison
Compare LVO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- PDSB
- Stock Information
- Founded
- LVO 2009
- PDSB 2005
- Country
- LVO United States
- PDSB United States
- Employees
- LVO N/A
- PDSB N/A
- Industry
- LVO Restaurants
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- PDSB Health Care
- Exchange
- LVO Nasdaq
- PDSB Nasdaq
- Market Cap
- LVO 61.3M
- PDSB 72.2M
- IPO Year
- LVO N/A
- PDSB N/A
- Fundamental
- Price
- LVO $0.74
- PDSB $1.38
- Analyst Decision
- LVO Strong Buy
- PDSB Strong Buy
- Analyst Count
- LVO 1
- PDSB 2
- Target Price
- LVO $1.50
- PDSB $10.00
- AVG Volume (30 Days)
- LVO 291.3K
- PDSB 713.0K
- Earning Date
- LVO 06-10-2025
- PDSB 05-14-2025
- Dividend Yield
- LVO N/A
- PDSB N/A
- EPS Growth
- LVO N/A
- PDSB N/A
- EPS
- LVO N/A
- PDSB N/A
- Revenue
- LVO $126,016,000.00
- PDSB N/A
- Revenue This Year
- LVO N/A
- PDSB N/A
- Revenue Next Year
- LVO N/A
- PDSB N/A
- P/E Ratio
- LVO N/A
- PDSB N/A
- Revenue Growth
- LVO 11.43
- PDSB N/A
- 52 Week Low
- LVO $0.55
- PDSB $0.85
- 52 Week High
- LVO $1.89
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- LVO 47.45
- PDSB 51.31
- Support Level
- LVO $0.71
- PDSB $1.33
- Resistance Level
- LVO $0.79
- PDSB $1.47
- Average True Range (ATR)
- LVO 0.07
- PDSB 0.12
- MACD
- LVO -0.01
- PDSB -0.01
- Stochastic Oscillator
- LVO 14.23
- PDSB 30.63
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.